A detailed history of Health Cor Management, L.P. transactions in Dexcom Inc stock. As of the latest transaction made, Health Cor Management, L.P. holds 321,380 shares of DXCM stock, worth $25.8 Million. This represents 34.39% of its overall portfolio holdings.

Number of Shares
321,380
Previous 253,500 26.78%
Holding current value
$25.8 Million
Previous $20.4 Million 78.25%
% of portfolio
34.39%
Previous 2.55%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $5.77 Million - $8.33 Million
67,880 Added 26.78%
321,380 $36.4 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $13.6 Million - $16.8 Million
178,720 Added 238.99%
253,500 $20.4 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $5.08 Million - $9.94 Million
74,780 New
74,780 $5.57 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $5.43 Million - $7.29 Million
-50,890 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$80.99 - $107.93 $7.39 Million - $9.85 Million
-91,220 Reduced 64.19%
50,890 $21.7 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $12 Million - $14.9 Million
142,110 New
142,110 $51.1 Million
Q2 2019

Aug 14, 2019

SELL
$27.84 - $38.92 $20.3 Million - $28.4 Million
-730,100 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$28.07 - $38.18 $20.7 Million - $28.2 Million
-738,652 Reduced 50.29%
730,100 $87 Million
Q4 2018

Feb 14, 2019

BUY
$26.99 - $37.37 $23.1 Million - $31.9 Million
854,122 Added 138.97%
1,468,752 $176 Million
Q4 2018

Feb 14, 2019

BUY
$26.99 - $37.37 $3.78 Million - $5.23 Million
139,950 Added 29.48%
614,630 $58.4 Million
Q3 2018

Nov 15, 2018

SELL
$23.35 - $36.72 $3.27 Million - $5.14 Million
-139,950 Reduced 22.77%
474,680 $67.9 Million
Q2 2018

Aug 14, 2018

BUY
$17.54 - $25.22 $10.8 Million - $15.5 Million
614,630 New
614,630 $58.4 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Health Cor Management, L.P. Portfolio

Follow Health Cor Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.